You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):終止氨氯地平阿託伐他汀鈣片項目的相關合作
格隆匯 08-02 15:45

格隆匯8月2日丨國藥現代(600420.SH)公佈,結合市場競爭格局的變化情況,公司經與吉林德商友好協商,將終止氨氯地平阿託伐他汀鈣片(5mg/10mg、5mg/20mg)項目的相關合作,並簽署了《終止協議》。雙方確認氨氯地平阿託伐他汀鈣片(5mg/10mg、5mg/20mg)的《藥品上市許可轉讓合同》終止,並積極開展後續合作項目的探討。如雙方就新項目達成協議,則公司已支付的氨氯地平阿託伐他汀鈣片項目款項1,250萬元將作為新項目首付款的一部分;如雙方未能就新項目達成協議,吉林德商退還公司已經支付的合同款1,250萬元,同時,公司需向吉林德商支付原合同總金額20%的違約金即500萬元。

上述項目的合作終止,不影響雙方有關奧美沙坦酯氫氯噻嗪片(20mg/12.5mg)合同的履行。奧美沙坦酯氫氯噻嗪片(20mg/12.5mg)上市許可持有人已於2023年6月變更為國藥現代,後續雙方將繼續推進技術轉移、生產地址變更等事項。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account